TTOO insider transactions
T2 Biosystems Inc. (TTOO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TTOO
- SEC Form 4 filed by Director Liebman Seymour4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Giffin Brett A.4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Director Adams Laura Lee4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Director Cumming John W4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by General Counsel Gibbs Michael Terrence4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Director Saunders Ninfa4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Director Toft Robin4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Officer Sperzel John J Iii4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Director Elsbree David B4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by CFO Sprague John M4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Director Elsbree David B sold $133 worth of shares (55 units at $2.42), decreasing direct ownership by 71% to 23 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. converted options into 1,824,800 shares (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. was granted 4,748,335 shares (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. was granted 3,280,618 shares (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Sperzel John J Iii converted options into 67 shares, increasing direct ownership by 20% to 400 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Gibbs Michael Terrence converted options into 29 shares, increasing direct ownership by 27% to 135 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Sprague John M converted options into 29 shares, increasing direct ownership by 26% to 141 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Gibbs Michael Terrence converted options into 40 shares, increasing direct ownership by 61% to 106 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Sperzel John J Iii converted options into 160 shares, increasing direct ownership by 92% to 333 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Sprague John M converted options into 40 shares, increasing direct ownership by 56% to 112 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Giffin Brett A. converted options into 13 shares, increasing direct ownership by 20% to 77 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. converted options into 824,220 shares (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Toft Robin4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Giffin Brett A. converted options into 33 shares, increasing direct ownership by 106% to 64 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Giffin Brett A. converted options into 1,333 shares and sold $349 worth of shares (537 units at $0.65), increasing direct ownership by 35% to 3,049 units (SEC Form 4) (Amendment)4/A - T2 Biosystems, Inc. (0001492674) (Issuer)
- Adams Laura Lee converted options into 7 shares, increasing direct ownership by 23% to 37 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Elsbree David B converted options into 2,300 shares, increasing direct ownership by 42% to 7,824 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Toft Robin converted options into 2,300 shares, increasing direct ownership by 66% to 5,772 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Saunders Ninfa converted options into 2,300 shares, increasing direct ownership by 46% to 7,322 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cumming John W converted options into 2,600 shares, increasing direct ownership by 98% to 5,256 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Adams Laura Lee converted options into 2,300 shares, increasing direct ownership by 314% to 3,032 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Liebman Seymour converted options into 2,300 shares, increasing direct ownership by 49% to 7,002 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Bernard Thierry converted options into 2,300 shares, increasing direct ownership by 46% to 7,322 units (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. sold $2,271,957 worth of shares (13,130,147 units at $0.17) (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. sold $1,082,359 worth of shares (5,392,920 units at $0.20) (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. sold $62,500 worth of shares (250,000 units at $0.25) (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. sold $1,314,534 worth of shares (5,079,344 units at $0.26) (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- Cr Group L.P. sold $1,904,632 worth of shares (6,338,211 units at $0.30) (SEC Form 4)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Cr Group L.P. sold $2,408,302 worth of shares (7,753,710 units at $0.31)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Cr Group L.P. sold $3,806,937 worth of shares (10,401,466 units at $0.37)4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Bernard Thierry converted options into 2,004 shares, increasing direct ownership by 66% to 5,022 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Toft Robin converted options into 454 shares, increasing direct ownership by 15% to 3,472 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Saunders Ninfa converted options into 2,004 shares, increasing direct ownership by 66% to 5,022 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Cr Group L.P. (Amendment)4/A - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Cr Group L.P.4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 3 filed by new insider Cr Group L.P.3 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Gibbs Michael Terrence4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Gibbs Michael Terrence (Amendment)4/A - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Gibbs Michael Terrence4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Sprague John M converted options into 6,914 shares and sold $1,682 worth of shares (2,693 units at $0.62) as part of a pre-agreed trading plan, increasing direct ownership by 139% to 7,268 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Giffin Brett A. converted options into 1,333 shares and sold $349 worth of shares (537 units at $0.65) as part of a pre-agreed trading plan, increasing direct ownership by 1,769% to 841 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Adams Laura Lee converted options into 732 shares4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Gibbs Michael Terrence converted options into 6,914 shares and sold $2,329 worth of shares (3,730 units at $0.62) as part of a pre-agreed trading plan, increasing direct ownership by 96% to 6,517 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Sperzel John J Iii converted options into 22,667 shares and sold $6,179 worth of shares (9,773 units at $0.63) as part of a pre-agreed trading plan, increasing direct ownership by 291% to 17,329 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4: Giffin Brett A. converted options into 3,333 shares and sold $2,317 worth of shares (1,292 units at $1.79), increasing direct ownership by 963% to 2,253 units4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Liebman Seymour4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Saunders Ninfa4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Elsbree David B4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Adams Laura Lee4 - T2 Biosystems, Inc. (0001492674) (Issuer)
- SEC Form 4 filed by Toft Robin4 - T2 Biosystems, Inc. (0001492674) (Issuer)